More>Health>Recovery

Atrial Fibrillation Treatment Options in Cardiology

Atrial fibrillation (AFib) is a common heart rhythm disorder that requires careful management to prevent complications and improve quality of life. Effective treatment strategies typically involve multiple approaches tailored to the individual patient's needs. Below are the key components of AFib treatment:

Stroke Prevention

One of the primary concerns in managing atrial fibrillation is reducing the risk of stroke. All AFib patients should undergo a thromboembolic risk assessment using the CHA2DS2-VASc scoring system. Patients with a score of 2 or higher, and who are not at high risk for bleeding, should consider anticoagulation therapy. This may include traditional medications like warfarin or newer direct oral anticoagulants (DOACs), which offer improved safety profiles and convenience.

Heart Rate Control

Maintaining a healthy heart rate is crucial for symptom management and heart function. Doctors often prescribe long-term medications that slow the heart rate, aiming to keep resting heart rates around 80 beats per minute and active rates below 110 beats per minute. In cases where medications are ineffective, more advanced interventions such as atrioventricular (AV) node ablation combined with permanent pacemaker implantation may be recommended to regulate heart rhythm effectively.

Rhythm Control

Restoring and maintaining normal sinus rhythm is another important treatment goal. This can be achieved through pharmacological cardioversion using antiarrhythmic drugs or electrical cardioversion, which delivers a controlled electric shock to reset the heart's rhythm. Some patients may benefit from long-term antiarrhythmic therapy to sustain normal rhythm. Additionally, catheter ablation—particularly radiofrequency ablation—is a viable option for selected patients. Those under 65 years of age, with a shorter duration of AFib and a left atrial size smaller than 45mm, tend to have higher success rates with this procedure.

ArcticFish2025-08-02 08:53:33
Comments (0)
Login is required before commenting.